Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Turnaround Potential
1314.2000 6.40 (0.49%)
NSE Mar 27, 2026 15:31 PM
Volume: 1.9M
 

1314.20
0.49%
Motilal Oswal
Under the Production-Linked Incentive (PLI) scheme, ARBP constructed the PENG and 6-APA plants within a record three-year period and ramped up production following the start of the PEN-G plant in Jul’25.
Motilal Oswal increased Buy price target of Aurobindo Pharma Ltd. to 1500.0 on 23 Mar, 2026.
More from Aurobindo Pharma Ltd.
Recommended